ENANTA PHARMACEUTICALS INC (ENTA) Stock News
NASDAQ:ENTA - Nasdaq - US29251M1062 - Common Stock - Currency: USD
ENTA Latest News, Press Relases and Analysis
AbbVie Secures FDA Approval to Expand Mavyret’s Label
AbbVie Inc. (NYSE:ABBV) is one of the best stocks for a dividend stock portfolio. The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in partnership with Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), for treating Hepatitis C. The updated approval allows Mavyret—made from the antiviral agents glecaprevir and […]
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data.
Mentions: ABBV
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
AMAT Earnings: Demand Holding Up So Far
Applied Materials beat analyst expectations for earnings but missed on revenue. The company said that customer demand hasn’t changed due to an uncertain economic environment. Applied Materials’ outlook for the third quarter included wide ranges for revenue and adjusted earnings per share.
Does Enanta Pharmaceuticals (ENTA) Have the Potential to Rally 189.58% as Wall Street Analysts Expect?
The consensus price target hints at an 189.6% upside potential for Enanta Pharmaceuticals (ENTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of -1.92% and 8.71%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PSTV
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
The analyst behind the change is now bullish on Teva's future. A positive change in recommendation from a well-known bank was the fuel propelling Teva Pharmaceutical Industries's (NYSE: TEVA) well higher on Monday. The company, known for being a top producer of generic drugs, saw its share price swell almost 6% as a result.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2025
Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates
Profound Medical (PROF) delivered earnings and revenue surprises of -24.14% and 24.03%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PROF
Matrix Service Company (MTRX): Among the Best Breakout Stocks to Buy According to Analysts
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Matrix Service Company (NASDAQ:MTRX) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive […]
Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive […]
Gogo Inc. (GOGO): Among the Best Breakout Stocks to Buy According to Analysts
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Gogo Inc. (NASDAQ:GOGO) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive trade […]
Enanta Pharmaceuticals, Inc. (ENTA): The Best Breakout Stock to Buy According to Analysts
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive […]
Is Oracle Corporation (ORCL) A Hidden AI Stock to Buy Right Now?
We recently published a list of the 11 Hidden AI Stocks to Buy Right Now. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against other hidden AI stocks. David Grain, Founder & CEO of Grain Management, joined CNBC on May 1 to discuss the AI-driven demand for […]
Trading Day: Tariff uncertainty still runs deep
A relatively quiet day on Monday with some key markets closed saw Asian and European stocks extend their recent rebound but Wall Street stumble after U.S. President Donald Trump's latest tariff salvo, despite more signs of underlying strength in the U.S. economy. World markets are in limbo, with investors hoping for concrete progress in Washington's bilateral trade deal talks with dozens of countries but wary that the rally in risk assets over the past month could be losing momentum.
Why Mara Holdings Stock Plummeted Today
Mara Holdings is struggling to produce Bitcoin, reporting a 15% drop month over month. Global hashrate is up, making it more difficult for Mara to mine Bitcoin. Mara, a Bitcoin mining company, released its April production update on Monday.
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
